GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Changjiang Pharmaceutical Group Co Ltd (SZSE:300391) » Definitions » Additional Paid-In Capital

Changjiang Pharmaceutical Group Co (SZSE:300391) Additional Paid-In Capital : ¥0.0 Mil(As of Sep. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Changjiang Pharmaceutical Group Co Additional Paid-In Capital?


Changjiang Pharmaceutical Group Co's quarterly additional paid-in capital increased from Mar. 2024 (¥0.0 Mil) to Jun. 2024 (¥788.2 Mil) but then stayed the same from Jun. 2024 (¥788.2 Mil) to Sep. 2024 (¥0.0 Mil).

Changjiang Pharmaceutical Group Co's annual additional paid-in capital stayed the same from Dec. 2021 (¥788.1 Mil) to Dec. 2022 (¥788.1 Mil) but then increased from Dec. 2022 (¥788.1 Mil) to Dec. 2023 (¥788.2 Mil).


Changjiang Pharmaceutical Group Co Additional Paid-In Capital Historical Data

The historical data trend for Changjiang Pharmaceutical Group Co's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Changjiang Pharmaceutical Group Co Additional Paid-In Capital Chart

Changjiang Pharmaceutical Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 788.07 788.07 788.07 788.07 788.17

Changjiang Pharmaceutical Group Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 788.17 - 788.17 -

Changjiang Pharmaceutical Group Co Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Changjiang Pharmaceutical Group Co Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Changjiang Pharmaceutical Group Co's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Changjiang Pharmaceutical Group Co Business Description

Traded in Other Exchanges
N/A
Address
Shouguang Development Zone, Shandong, CHN, 262700
Changjiang Pharmaceutical Group Co Ltd is engaged in the production and sales of decoction pieces of traditional Chinese medicine and medicinal capsules, as well as the wholesale of medicines, health products and medical devices.
Executives
Zong Jun Directors, executives
Wang Hang Executives

Changjiang Pharmaceutical Group Co Headlines

No Headlines